Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy

by Leanne G. Ahronian, Ryan B. Corcoran
Published 2017-04-01

Radiation precautions for inpatient and outpatient 177Lu-DOTATATE peptide receptor radionuclide therapy of neuroendocrine tumours

by D. Levart, E. Kalogianni, B. Corcoran, N. Mulholland, G. Vivian
Published 2019-04-01

Pyrrolobenzodiazepines (PBDs) do not bind to DNA G-quadruplexes.

by Khondaker M Rahman, David B Corcoran, Tam T T Bui, Paul J M Jackson, David E Thurston
Published 2014-01-01

Data on the modulatory effects of a single bolus dexamethasone on the surface marker expression of various leucocyte subsets

by D.F. Draxler, C.R. Bain, R. Taylor, S. Wallace, O. Gouldthorpe, T.B. Corcoran, P.S. Myles, K. Bozaoglu, R.L. Medcalf
Published 2020-10-01

Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots

by Pégah Jalili, Danae Bowen, Adam Langenbucher, Shinho Park, Kevin Aguirre, Ryan B. Corcoran, Angela G. Fleischman, Michael S. Lawrence, Lee Zou, Rémi Buisson
Published 2020-06-01

A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma

by Meghan J. Mooradian, Alexandre Reuben, Peter A. Prieto, Mehlika Hazar-Rethinam, Dennie T. Frederick, Brandon Nadres, Adriano Piris, Vikram Juneja, Zachary A. Cooper, Arlene H. Sharpe, Ryan B. Corcoran, Keith T. Flaherty, Donald P. Lawrence, Jennifer A. Wargo, Ryan J. Sullivan
Published 2018-05-01

Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis

by Sophia C. Kamran, Jeffrey W. Clark, Hui Zheng, Darrell R. Borger, Lawrence S. Blaszkowsky, Jill N. Allen, Eunice L. Kwak, Jennifer Y. Wo, Aparna R. Parikh, Ryan D. Nipp, Janet E. Murphy, Lipika Goyal, Andrew X. Zhu, A. John Iafrate, Ryan B. Corcoran, David P. Ryan, Theodore S. Hong
Published 2018-07-01

Resistance to checkpoint blockade therapy through inactivation of antigen presentation

by Moshe Sade-Feldman, Yunxin J. Jiao, Jonathan H. Chen, Michael S. Rooney, Michal Barzily-Rokni, Jean-Pierre Eliane, Stacey L. Bjorgaard, Marc R. Hammond, Hans Vitzthum, Shauna M. Blackmon, Dennie T. Frederick, Mehlika Hazar-Rethinam, Brandon A. Nadres, Emily E. Van Seventer, Sachet A. Shukla, Keren Yizhak, John P. Ray, Daniel Rosebrock, Dimitri Livitz, Viktor Adalsteinsson, Gad Getz, Lyn M. Duncan, Bo Li, Ryan B. Corcoran, Donald P. Lawrence, Anat Stemmer-Rachamimov, Genevieve M. Boland, Dan A. Landau, Keith T. Flaherty, Ryan J. Sullivan, Nir Hacohen
Published 2017-10-01